SOPHiA GENETICS SA (SOPH)
After hours:
Chart Events
Performance Outlook
| Previous Close | 4.5900 |
| Open | 4.6800 |
| Bid | 1.7600 x 1000 |
| Ask | 7.0000 x 1000 |
| Day's Range | 4.2600 - 4.6800 |
| 52 Week Range | 4.2600 - 19.8000 |
| Volume | |
| Avg. Volume | 70,544 |
| Market Cap | 275.865M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2250 |
| Earnings Date | Sep 09, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.00 |
- GlobeNewswire
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2022
Steady Start to 2022; FY 2022 Constant Currency Revenue Growth Guidance ReaffirmedBOSTON, United States and LAUSANNE, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2022. Recent Highlights Revenue for the first quarter of 2022 was $10.9 million, representing year-over-year revenue growth of 21%Constant currency revenue growth excluding COVID-19-related revenu
- Simply Wall St.
Here's What SOPHiA GENETICS SA's (NASDAQ:SOPH) Shareholder Ownership Structure Looks Like
The big shareholder groups in SOPHiA GENETICS SA ( NASDAQ:SOPH ) have power over the company. Insiders often own a...
- PR Newswire
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors
SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced the nomination of Jean-Michel Cosséry to its Board of Directors. The Board of Directors will propose the appointment of Mr. Cosséry as a member of the Board of Directors and a member of the Compensation Committee to the Annual General Meeting of Shareholders of SOPHiA GENETICS SA, to convene on June 15, 2022.
